Skip to main
MPLT

MPLT Market Capitalization Overview

Market Cap: $552.80M as of Sep 25, 2026

$552.80M
$126.84M (18.66%)past month
As of Sep 25, 2026, MPLT has a market capitalization of $552.80M. Over the past 30 days, its market cap has increased by 31.51%, while in the last 12 months, it has decreased by -30.64%.

Market capitalization represents the total value of MapLight Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

MPLT Market Cap Formula = Stock Price * Shares Outstanding

The market cap of MPLT helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MPLT Market Cap History

DateMarket CapChange
Sep 1, 2026$703.41M+31.51%
Aug 3, 2026$534.86M-65.22%
Jul 1, 2026$1.54B+21.24%
Jun 1, 2026$1.27B-2.65%
May 1, 2026$1.31B+47.38%
Apr 1, 2026$883.95M+10.69%
Mar 2, 2026$798.57M-1.84%
Feb 2, 2026$813.54M+6.92%
Jan 2, 2026$760.91M+35.15%

MPLT End of Year Market Cap History

DateMarket CapChange
2026$552.80M-30.64%
2025$796.98M—

FAQs About MapLight Therapeutics Inc (MPLT) Market Cap

As of Sep 25, 2026, the market capitalization of MPLT is $552.80M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, MapLight Therapeutics Inc’s market capitalization has decreased by -18.66%, changing from $679.63M to $552.80M as of Sep 25, 2026.

In the last 3 months, MapLight Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, MapLight Therapeutics Inc’s market capitalization increased from – in January to $796.98M in December, reflecting a — change.

MapLight Therapeutics Inc (MPLT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.